Skip to main content

STORAGE FACILITY -40°C and -20°C Walk-in For Biotech Pharmaceuticals in North of Italy

Airpharm proudly announces the expansion of its service offerings by adding a new -40 °C and -20°C state-of-the-art pallet storage facility located at their partners facility, Dynamic Forwarding International S.r.l. in Rovello Porro (Como) , very close to Milan, Italy.

This strategic expansion underscores our commitment to providing unparalleled logistics and 3PL solutions to clients across the borders to Switzerland and allowing storage in the EU.

The new facility of Dynamic Forwarding International S.r.l. in Rovello Porro, Italy, offers a strategic location within a free-trade zone.

Storage sites are inspected by (ATS = Agenzia di Tutela della Salute) on behalf of the Italian Ministry of Health according to the Decree D.lgs 219/2006 anc fully comply to the GDP Regulations.

Advanced Storage Capabilities

The Dynamic Forwarding facility features an extensive range of temperature-controlled storage options designed to meet the diverse needs of pharmaceutical products:

  • Room Temperature Storage (15-25°C)
  • Cold Storage (2-8°C)
  • Frozen Storage (-20°C)
  • Low Temperature Storage (-40°C)

 

The -40°C pallet storage capability is particularly noteworthy. This specialized storage solution is critical for many new biologic products that require low temperatures to maintain their stability and efficacy. Adding this capability sets Airpharm apart from many other facilities, providing clients with this rare and highly sought-after service.

Strategic Benefits

Located within the European Union, the Italian facility offers significant strategic advantages for Airpharm’s clients. The bonded, free-trade zone status of the facility further enhances its appeal, offering clients streamlined logistics and reduced customs complexities.

Client-Centric Expansion

 

With this new facility, we are not only expanding our geographical reach but also enhancing our service offerings to include cutting-edge storage capabilities that are crucial for the next generation of biologic products.”

For more information contact Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein.